Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

SAMDC inhibitors from Ciba-Geigy

Sep. 20, 1996

Nitrogen mustard prodrugs from CRC Technology

Sep. 20, 1996

Daiichi's anticancer drugs in development

Sep. 13, 1996

Chugai's anticancer R&D pipeline

Sep. 13, 1996

Expanded approval sought for Photofrin

Sep. 13, 1996

Cytoprotective agent receives broad approval in Australia

Sep. 13, 1996

DNA repair gene isolated

Sep. 13, 1996

Site-specific catalytic cleavage of RNA achieved with ribozyme analogue

Sep. 13, 1996

Dolastatin 10 mimic dolaphenine androstane

Sep. 13, 1996

Antitumor agents from Samjin

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
US lawmakers demand that Kennedy be held accountable
BioWorld
As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...